Sang-oh Han

Sang-oh Han

UNVERIFIED PROFILE

Are you Sang-oh Han?   Register this Author

Register author
Sang-oh Han

Sang-oh Han

Publications by authors named "Sang-oh Han"

Are you Sang-oh Han?   Register this Author

17Publications

-Reads

Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction.

Mol Ther Methods Clin Dev 2017 Mar 11;4:126-136. Epub 2017 Jan 11.

Division of Medical Genetics, Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA; Department of Molecular Genetics and Microbiology, Duke University, Durham, NC 27710, USA.

View Article
March 2017

Salmeterol enhances the cardiac response to gene therapy in Pompe disease.

Mol Genet Metab 2016 May 18;118(1):35-40. Epub 2016 Mar 18.

Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, United States.

View Article
May 2016

Ubiquitin-specific Protease 20 Regulates the Reciprocal Functions of β-Arrestin2 in Toll-like Receptor 4-promoted Nuclear Factor κB (NFκB) Activation.

J Biol Chem 2016 Apr 2;291(14):7450-64. Epub 2016 Feb 2.

From the Departments of Medicine (Cardiology) and Cell Biology, Duke University Medical Center, Durham, North Carolina 27710

View Article
April 2016

A beta-blocker, propranolol, decreases the efficacy from enzyme replacement therapy in Pompe disease.

Mol Genet Metab 2016 Feb 3;117(2):114-9. Epub 2015 Oct 3.

Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, United States.

View Article
February 2016

Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β2-Agonist in Murine Pompe Disease.

Hum Gene Ther 2015 Nov 29;26(11):743-50. Epub 2015 Sep 29.

Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center , Durham, North Carolina.

View Article
November 2015

Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockade.

Hum Gene Ther 2015 Jan;26(1):26-35

1 Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center , Durham, NC 27710.

View Article
January 2015

Polyubiquitin is required for growth, development and pathogenicity in the rice blast fungus Magnaporthe oryzae.

PLoS One 2012 10;7(8):e42868. Epub 2012 Aug 10.

Center for Integrated Fungal Research, Department of Plant Pathology, North Carolina State University, Raleigh, North Carolina, United States of America.

View Article
March 2013

Distinct roles for β-arrestin2 and arrestin-domain-containing proteins in β2 adrenergic receptor trafficking.

EMBO Rep 2013 Feb 4;14(2):164-71. Epub 2012 Dec 4.

Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article
February 2013

MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β(2)-adrenergic receptors.

J Cell Biol 2012 Nov 19;199(5):817-30. Epub 2012 Nov 19.

Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.

View Article
November 2012

Activin A induces ovine follicle stimulating hormone beta using -169/-58 bp of its promoter and a simple TATA box.

Reprod Biol Endocrinol 2009 Jun 24;7:66. Epub 2009 Jun 24.

Department of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, 27695-7622, USA.

View Article
June 2009

Chronic gonadotropin-releasing hormone inhibits activin induction of the ovine follicle-stimulating hormone beta-subunit: involvement of 3',5'-cyclic adenosine monophosphate response element binding protein and nitric oxide synthase type I.

Endocrinology 2007 Jul 19;148(7):3346-55. Epub 2007 Apr 19.

Department of Molecular and Structural Biochemistry, Box 7622, North Carolina State University, Raleigh, North Carolina 27695-7622, USA.

View Article
July 2007

Synthesis and application of a non-viral gene delivery system for immunogene therapy of cancer.

J Control Release 2005 Dec 2;109(1-3):288-98. Epub 2005 Nov 2.

Expression Genetics, Inc., Huntsville, AL 35801, USA.

View Article
December 2005

Tumor regression by repeated intratumoral delivery of water soluble lipopolymers/p2CMVmIL-12 complexes.

J Control Release 2003 Feb;87(1-3):177-86

Department of Pharmaceutics and Pharmaceutical Chemistry, Center for Controlled Chemical Delivery, University of Utah, BPRB, Room 205, Salt Lake City, UT 84112, USA.

View Article
February 2003

An angiogenic, endothelial-cell-targeted polymeric gene carrier.

Mol Ther 2002 Nov;6(5):664-72

Department of Pharmaceutics and Pharmaceutical Chemistry, Center for Controlled Chemical Delivery, University of Utah, Salt Lake City 84112, USA.

View Article
November 2002

Prevention of autoimmune insulitis by delivery of interleukin-4 plasmid using a soluble and biodegradable polymeric carrier.

Pharm Res 2002 Mar;19(3):246-9

Center for Controlled Chemical Delivery, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City 84112, USA.

View Article
March 2002

Artery wall binding peptide-poly(ethylene glycol)-grafted-poly(L-lysine)-based gene delivery to artery wall cells.

J Control Release 2002 Jan;78(1-3):273-84

Department of Polymer Science and Engineering, Sunchon National University, 540-742, Chonnam, Republic of Korea.

View Article
January 2002